Startups
We help our partners develop and manufacture life-changing biologics. CDMO Services | Analytical, Mammalian, Microbial, & Cell Therapy.
Overview
Location
United States, North Carolina, Durham
Employees
1001-5000
Phone
+1 919-479-9898
Founded date
1996
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 3, 2020 | KBI plans $150M facility in Research Triangle Park with mystery co-investor | A month after unveiling plans for a new manufacturing facility in Geneva, KBI Biopharma has already pegged the location for its next site: a $150 million facility in Research Triangle Park, North Carolina. The 140,0... |
| Oct 24, 2017 | GlycoSelect Completes €450,000 Seed Round | Biotech specialist GlycoSelect has completed a seed funding round of €450,000 with investments from Enterprise Ireland and KBI Biopharma, a US contract development and manufacturing company based in Durham, North Carolina. The company said ... |
| Jun 14, 2017 | JSR Life Sciences Acquires Selexis | |
| KBI Biopharma | “KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, and more. ” |
Reviews 0
FAQ about KBI Biopharma
When was KBI Biopharma founded?
KBI Biopharma was founded in 1996.
What has the press written about KBI Biopharma?
Parsers VC has collected 5 articles mentioning KBI Biopharma, among them “KBI plans $150M facility in Research Triangle Park with mystery co-investor” (Dec 3, 2020) and “GlycoSelect Completes €450,000 Seed Round” (Oct 24, 2017).
Is KBI Biopharma still active?
KBI Biopharma is probably closed: its latest activity on Parsers VC dates from Jun 17, 2024.